Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 7 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 1

3(42.9%)

N/A

3(42.9%)

Phase 2

1(14.3%)

7Total

Phase 1(3)

N/A(3)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT03075943Not ApplicableCompleted

Brown Seaweed Extract on Glycemic Control and Body Weight

Role: collaborator

NCT03328923Not ApplicableCompleted

Effects of Seaweed Extract on Mental Performance Following a High-carbohydrate Meal

Role: collaborator

NCT02853916Not ApplicableCompleted

Efficacy of a Brown Seaweed Powder for Glycemic Control

Role: collaborator

NCT01384110Phase 1Completed

Efficacy of a Brown Seaweed Extract Rich in Polyphenols on Glycemic Response to Sucrose in Human

Role: lead

NCT00797394Phase 2Completed

Efficacy of Natural Extract 2007RD01 Combined With Saw Palmetto in Benign Prostatic Hyperplasia Patients Compared to Saw Palmetto

Role: lead

NCT00936754Phase 1Completed

Safety and Efficacy of a Single Dose of a Polyphenol-enriched Brown Seaweed Powder in Human

Role: lead

NCT00906438Phase 1Completed

Effects of 2006-RD-05 on Salivary and Serum Immunoglobulin A (IgA) Levels in Healthy Subjects

Role: lead

All 7 trials loaded